INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

Curcuminoids lowered fasting glucose and HbA1c in overweight patients with type 2 diabetes.

A double-blind, randomized, placebo-controlled trial assigned 100 overweight or obese patients with type 2 diabetes to receive 300 mg daily of curcuminoids or placebo for three months. Curcuminoid supplementation significantly reduced fasting blood glucose (p < 0.01), HbA1c (p = 0.031), and homeostatic model assessment of insulin resistance (p < 0.01). Participants receiving curcuminoids also experienced significant reductions in serum free fatty acids and triglycerides alongside elevated lipoprotein lipase activity.

Study type
Randomized controlled trial
Who was studied
100 overweight or obese adults with type 2 diabetes
What was measured
Fasting blood glucose, HbA1c, insulin resistance, and serum lipids

THE PAPER

Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.

Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, Li XX, Sun CH. Mol Nutr Food Res, 2013.

PubMed 22930403 ↗DOI 10.1002/mnfr.201200131 ↗

Diabetes & blood sugarNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.